PHARMACOTHERAPY OF SUPRAVENTRICULAR TACHYCARDIA

1. Orejarena L.A., Vidaillet H.J., De Stefano F. et al. Paroxysmal supraventricular tachycardia in the general population //J. Am. Coll. Cardiol. 1998; 31: 150-157.

2. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary// Eur. Heart J. 2003; 24: 1857-1897.

3. Saoudi N., Cosio F., Waldo A. et al. A classification on atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases//Eur.HeartJ.2001;22(14):1162- 1182.

4. Chen S.A., Chiang C.E., Yang C.J. et al. Sustained atrial tachycardia in adult patients// Circulation. 1994; 90: 1262-1278.

5. Roberts-Thomson K.C., Kistler P.M., Kalman J.M. Atrial tachycardia: mechanisms, diagnosis and management// Curr. Probl. Cardiol. 2005; 30: 529-573.

6. Berns E., Rinkenberger R.L. Jeang M.K. et al. Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation// Am. J. Cardiol. 1987; 59: 1337-1341.

7. Lucet V., Do N.D., Fidelle J. Anti-arrhythmia efficacy of propafenone in children// Arch. Mal. Coeur Vaiss. 1987; 80: 1385- 1393.

8. Colloridi V., Perri C., Ventriglia F. et al. Oral sotalol in pediatric atrial ectopic tachycardia// Am. Heart J. 1992; 123: 254-256.

9. Guccione P., Paul T., Garson A. Long-term follow-up of amiodarone therapy in the young// J. Am. Coll. Cardiol. 1990; 15: 1118-1124.

10. Prager N.A., Cox J.L., Lindsay B.D. et al. Long-term effectiveness of surgical treatment of ectopic atrial tachycardia// J. Am. Coll. Cardiol. 1993; 22: 85-92.

11. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Group// Circulation. 1995; 92: 2550-2557.

12. Kastor J.A. Multifocal atrial tachycardia / In Kastor J.A. (eds). Arrhythmias. Philadelphia: W.B.Saunders Company. 1994; p. 133- 144.

13. Reimer A., Paul T., Kallfelz H-C. Efficacy and safety of intravenous and oral propafenone in pediatric cardiac dysrhythmia// Am. J. Cardiol. 1991; 68: 741-744.

14. Iseri L.T., Fairshter R.D., Hardemann J.L., Brodsky M.A. Magnesium and potassium therapy in multifocal atrial tachycardia// Am. Heart. J. 1985; 110: 789-794.

15. Flammang D., Coumel P. Supraventricular tachycardia with re-entry in the sinus node or atria / In Kastor J.A. (eds). Arrhythmias. Philadelphia: W.B.Sounders Company. 1994; p. 297-309.

16. Wellens H.J. Supraventricular tachycardia with reentry in the atrioventricular node/In Kastor J.A. (eds). Arrhythmias. Philadelphia: W.B.Saunders company. 1994; p. 250-261.

17. Garcia-Civera R., Sanjuan R., Morell S. et al. Effect of propafenone on induction and maintenance of atrioventricular nodal reentrant tachycardia // PACE. 1984; 7: 649.

18. a. Малахов В.И., Шугушев Х.Х. Механизмы действия и эффективность этацизина у больных с пароксизмальной атриовентрикулярной узловой реципрокной тахикардией//Кардиология. 1986; 4: 48-54.

19. Ferguson J.D., Di Marco J.P. Contemporary management of paroxysmal supraventricular tachycardia// Circulation. 2003; 107: 1096-1099.

20. Gallagher J.J. Supraventricular tachycardia with reentry in accessory pathways / In Kastor J.A. (eds). Arrhythmias. Philadelphia: W.B.Sounders Company. 1994; p. 262-296

21. Zardini M., Yee R., Thakur R.K. et al. Risk of sudden arrhythmic death in the WPW syndrome// Current perspectives Pacing Clin. Electrophysiol. 1994; 17: 966-975.

22. Olgin E.J., Zipes D.P. Specific arrhythmias: diagnosis and treatment. /In Braunwald E., Zipes D., Libby P., Bonow R. (eds). Heart disease. Saunders Company. 2005; p. 803-863.

23. Manolis A.S., Katsaros C., Cokkinos D.V. Electrophysiological and electropharmacological studies in pre-excitation syndromes: results with propafenone therapy and isoproterenol infusion testing// Eur. Heart J. 1992; 13: 1489-1495.

24. Vignati G., Mauri L., Figini A. The use propafenone in the treatment of tachyarrhythmias in children// Eur. Heart J. 1993; 14: 546-550.

25. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures// JACC. 1995; 26: 555-573.

26. Gillette P.C., Case C.L., Kastor J.A. Junctional ectopic tachycardia./ In Kastor J.A. (eds). Arrhythmias. Philadelphia: W.B.Saunders company. 1994; p. 218-224.

27. Paul T. et al. Efficacy and safety propafenone in congential junctional ectopic tachycardia// J. Am. Coll. Cardiol. 1992; 20: 911-914.

28. Villain E., Vetter V.L., Garsia J.M. et al. Evolving concepts in the management of congential junctional ectopic tachycardia. A multicenter study// Circulation. 1990; 81: 1544-1549.